<style face="normal" font="default" size="100%">Consideration of ways in the post-marketing setting and, absent conducting RCTs, to obtain data supporting use and dosing recommendations of novel medications in later CKD stages</style>

Drupal-Bibcite

31<style face="normal" font="default" size="100%">Consideration of ways in the post-marketing setting and, absent conducting RCTs, to obtain data supporting use and dosing recommendations of novel medications in later CKD stages</style>